BCL2 and non-small cell lung carcinoma: Overexpression of the bcl-2 gene was also observed in certain solid tumors such as neoplasms of the colon (90%), gastrointestinal tract (60%), prostate carcinoma (30%), non-small cell lung carcinoma (20%) and melanoma [15,16].